Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade
With the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2013/267630 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554436564615168 |
---|---|
author | Junjie Xu Minyue Tang Jun Shen |
author_facet | Junjie Xu Minyue Tang Jun Shen |
author_sort | Junjie Xu |
collection | DOAJ |
description | With the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization costs and factors impacting cost changes were determined. Patients with IBD and frequency of hospitalizations increased significantly from 2003 to 2011 (P<0.001). The annual hospitalization cost per patient, cost per hospitalization, and daily cost during hospitalization increased significantly in the past decade (all P<0.001). However, length of stay decreased significantly (P<0.001). Infliximab was the most significant factor associated with higher hospitalization cost (OR = 44380.09, P<0.001). Length of stay (OR = 1.29, P<0.001), no medical insurance (OR = 1.31, P=0.017), CD (OR = 3.55, P<0.001), inflammatory bowel disease unclassified (IBDU) (OR = 4.30, P<0.0001), poor prognosis (OR = 6.78, P<0.001), surgery (OR = 3.16, P<0.001), and endoscopy (OR = 2.44, P<0.001) were found to be predictors of higher hospitalization costs. Patients with IBD and frequency of hospitalizations increased over the past decade. CD patients displayed a special one peak for age at diagnosis, which was different from UC patients. The increased hospitalization costs of IBD patients may be associated with infliximab, length of stay, medical insurance, subtypes of IBD, prognosis, surgery, and endoscopy. |
format | Article |
id | doaj-art-93523fb7372e4991a6ccc6b468065fe2 |
institution | Kabale University |
issn | 1687-6121 1687-630X |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Gastroenterology Research and Practice |
spelling | doaj-art-93523fb7372e4991a6ccc6b468065fe22025-02-03T05:51:29ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/267630267630Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past DecadeJunjie Xu0Minyue Tang1Jun Shen2Department of Medicine, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, 160 Pu Jian Avenue, Shanghai 200127, ChinaDepartment of Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijiner Road, Shanghai 200025, ChinaDepartment of Gastroenterology, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Inflammatory Bowel Disease Research Center, 160 Pu Jian Avenue, Shanghai 200127, ChinaWith the growing number of patients with inflammatory bowel disease (IBD) and hospitalization cases, the overall medical care cost elevates significantly in consequence. A total of 2458 hospitalizations, involving 1401 patients with IBD, were included from two large medical centers. Hospitalization costs and factors impacting cost changes were determined. Patients with IBD and frequency of hospitalizations increased significantly from 2003 to 2011 (P<0.001). The annual hospitalization cost per patient, cost per hospitalization, and daily cost during hospitalization increased significantly in the past decade (all P<0.001). However, length of stay decreased significantly (P<0.001). Infliximab was the most significant factor associated with higher hospitalization cost (OR = 44380.09, P<0.001). Length of stay (OR = 1.29, P<0.001), no medical insurance (OR = 1.31, P=0.017), CD (OR = 3.55, P<0.001), inflammatory bowel disease unclassified (IBDU) (OR = 4.30, P<0.0001), poor prognosis (OR = 6.78, P<0.001), surgery (OR = 3.16, P<0.001), and endoscopy (OR = 2.44, P<0.001) were found to be predictors of higher hospitalization costs. Patients with IBD and frequency of hospitalizations increased over the past decade. CD patients displayed a special one peak for age at diagnosis, which was different from UC patients. The increased hospitalization costs of IBD patients may be associated with infliximab, length of stay, medical insurance, subtypes of IBD, prognosis, surgery, and endoscopy.http://dx.doi.org/10.1155/2013/267630 |
spellingShingle | Junjie Xu Minyue Tang Jun Shen Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade Gastroenterology Research and Practice |
title | Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade |
title_full | Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade |
title_fullStr | Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade |
title_full_unstemmed | Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade |
title_short | Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade |
title_sort | trends and factors affecting hospitalization costs in patients with inflammatory bowel disease a two center study over the past decade |
url | http://dx.doi.org/10.1155/2013/267630 |
work_keys_str_mv | AT junjiexu trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade AT minyuetang trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade AT junshen trendsandfactorsaffectinghospitalizationcostsinpatientswithinflammatoryboweldiseaseatwocenterstudyoverthepastdecade |